cro.directory
← Compare landing

ProSciento vs Raptim Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/prosciento/raptimresearch

CategoryProScientoRaptim Research
Listed sitecrocro
SummarySpecialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3.Bioequivalence and bioavailability specialist with 32+ USFDA inspections cleared, running healthy-subject BA/BE and PK/PD studies, IVRT/IVPT in-vitro release and permeability testing, and Phase I to IV clinical trials.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Clinical Trial Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Bioanalysis
  • In Vivo PK / PD Studies
  • Quality Control Testing
ModalitiesData not yet provided.
  • Biologics (Other)
Indications
  • Metabolic
  • Cardiovascular
  • Nephrology
Data not yet provided.
Locations
  • Headquarters, Chula Vista, California, United States
  • Navi Mumbai, Navi Mumbai, Maharashtra, India
  • Gandhinagar facility, Gandhinagar, Gujarat, India
  • Mumbai Phase I facility, Mumbai, Maharashtra, India
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.